AI-generated · cited to primary sources · not investment advice
Exicom Tele-Sys. (544133) Nov 2025 Filing Analysis
Does management do what it says?
The company has utilized almost all IPO funds as of September 30, 2025, with only a small residual amount remaining for the Hyderabad plant. (2 met across 2 tracked commitments)
“We are pretty much utilized all the IPO funds as per the plan that we had when we raised the funds. We have in Hyderabad as of 30th of September, INR17.29 crores still to be spent.”
The timeline for trial production has shifted slightly to November 2025 (a 1-month delay), with commercial production now set for January 2026. (2 revised, 1 met across 3 tracked commitments)
“Trial Production : Nov’25”
Anticipated addressable market for BSNL network upgradation tenders. — target: 330 Cr (130 Cr DC Systems + 200 Cr Li-ion)
“New Tender expected in Q3 resulting in FY27 addressable market of: DC Systems – 8,500 systems; estimated value 130 Cr Li-ion Battery – 50,000 qty, estimated value 200 Cr”
See the full cited Management analysis of Exicom Tele-Sys.
What could break the thesis?
Management has identified a clear path to breakeven by Q4 of next year, driven by the new 'Tri-Flex' product and a major fleet sector rollout starting in H2 2026. (1 stable, 1 easing)
“Tri-Flex, which is Tritium's latest product... the portfolio that Tritium currently has namely by RTM and PKM... that is aging. So it's imperative we bring new high-power chargers to the market.”
See the full cited Risk analysis of Exicom Tele-Sys.
AI-generated informational research only. ThesisLoop is not investment advice, a stock recommendation, or a guarantee of returns.